In Vivo Cell Seeding With Anti-CD34 Antibodies Successfully Accelerates Endothelialization but Stimulates Intimal Hyperplasia in Porcine Arteriovenous Expanded Polytetrafluoroethylene Grafts
Author(s) -
Jan Rotmans,
Jan M.M. Heyligers,
Hence J.M. Verhagen,
Evelyn Velema,
Machiel M. Nagtegaal,
Dominique P.V. de Kleijn,
Flip G. de Groot,
Erik S.G. Stroes,
Gerard Pasterkamp
Publication year - 2005
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.104.504407
Subject(s) - medicine , intimal hyperplasia , in vivo , polytetrafluoroethylene , seeding , cd34 , antibody , hyperplasia , pathology , smooth muscle , stem cell , microbiology and biotechnology , immunology , biology , materials science , engineering , metallurgy , aerospace engineering
The patency of AV expanded polytetrafluoroethylene (ePTFE) grafts for hemodialysis is impaired by intimal hyperplasia (IH) at the venous outflow tract. The absence of a functional endothelial monolayer on the prosthetic grafts is an important stimulus for IH. In the present study, we evaluated the feasibility of capturing endothelial progenitor cells in vivo using anti-CD34 antibodies on ePTFE grafts to inhibit IH in porcine AV ePTFE grafts.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom